NEW YORK (360Dx) – Grifols said today that it has inked an exclusive, long-term agreement with Beckman Coulter for the global distribution of Grifols' hemostasis instruments, reagents, and consumables.

The firms expect that under the distribution agreement, the first commercial systems will be available in Europe in early 2018.

Additional terms were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.